{name}
{subtitle}
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
city
~38 mi. (Norwich, United Kingdom, +159 more cities)
facility
Norfolk & Norwich University Hospital NHS Foundation Trust ( Site 0725)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +1 more type
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~38 mi. (Norwich, United Kingdom, +145 more cities)
facility
Norfolk and Norwich University Foundation NHS Trust ( Site 1805)
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~38 mi. (Norwich, United Kingdom, +156 more cities)
facility
Norfolk and Norwich University Hospitals NHS Foundation Trust /ID# 218213
biomarker
IGH-CCND1 Fusion, +1 more biomarker
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~42 mi. (Cambridge, United Kingdom, +226 more cities)
facility
Cambridge University Hospitals NHS Trust ( Site 0540)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~42 mi. (Cambridge, United Kingdom, +199 more cities)
facility
Cambridge University Hospitals NHS Trust ( Site 0755)
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)
city
~42 mi. (Cambridge, United Kingdom, +126 more cities)
facility
Cambridge University Hospitals NHS Trust ( Site 0477)
drug
FOLFOX regimen, +3 more drugs
drug type
chemotherapy, +2 more types